What is it about?
Due to the high prevalence of thromboembolic events reported in the literature in COVID19 patients in intensive care, the deep venous system of 13 consecutive patients diagnosed with neurovascular diseases and non-severe COVID-19 was investigated with a systematic bedside DUS,between March 20 and May 2, 2020, .
Featured Image
Why is it important?
Despite thromboprophylaxis, systematic bedside DUS showed a high prevalence (38.5%) of asymptomatic DVT in non-severe COVID-19 patients suffering from a neurovascular disease. In the absence of a reliable marker of DVT,in particular the dosage of D-Dimer which is disturbed in strokes, we suggest that this non-invasive investigation could be an interesting tool to monitor peripheral venous thrombotic complications in such patients.
Perspectives
Since it was suggested that DUS should be performed on all patients and integrated into medical care of COVID-19 patients, we suggest that a bedside venous DUS examination could be an interesting tool to monitor peripheral venous thrombotic complications.
Dr Olivier Rouyer
Universite de Strasbourg
Read the Original
This page is a summary of: High Prevalence of Deep Venous Thrombosis in Non-Severe COVID-19 Patients Hospitalized for a Neurovascular Disease, Cerebrovascular Diseases Extra, December 2020, Karger Publishers,
DOI: 10.1159/000513295.
You can read the full text:
Contributors
The following have contributed to this page
